科创板上市第5日普跌福光股份(688010.SH)跌12%领跌
格隆汇7月26日丨今天是科创板上市的第5日,也是最后一个涨跌幅没有限制的交易日,5个交易日过后,从下周一起,科创板个股将遵循涨跌幅20%的限制规则。今日科创板股普跌,25只个股中,仅嘉元科技、沃尔德和交控科技上涨,且涨幅均在3%以内,22只个股下跌,跌幅最大的是福光股份,跌12.7%,跌幅在5%以上的个股有16只。中国通号目前为成交额最大的个股,暂成交13.86亿元,也是科创板中市值最大的个股,最新总市值为961亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.